For Student Employees, Larry Elsasser Memorial Scholarship Fund Accepting Applications Through Sept. 25
Applications are being accepted through Sept. 25 for a scholarship in memory of well-known Bearcat alumnus Larry Elsasser (Ed 65, MEd 73).
The scholarship, awarded annually to two student employees working at UC, remembers the 35-year UC employee and longtime director of the Tangeman University Center. Campus Services staff established the Larry Elsasser Memorial Scholarship Fund in 2011 through the UC Foundation.
Applicants must meet certain criteria, including:
Application to the scholarship is open through Friday, Sept. 25, and will be awarded to two student employees working at UC, who meet the following criteria:
- The student must be enrolled as a full-time student at the University of Cincinnati;
- The student must be employed by the university as an enrolled student employee at the time of application for the scholarship and award;
- The student must have completed or is in the process of completing two semesters of academic work and hold a cumulative university grade point average of 3.0 or better; and
- The student must submit the required forms, including a reference from their supervisor at the university.
A university committee consisting of representatives from Campus Services and Student Affairs will review all applications submitted for the scholarship. Determination of the scholarship recipients will be based on:
- Completion of the required forms;
- Demonstrated need for the scholarship;
- Demonstrated work as a student employee; and
-
Supervisor review and comments.
The two awards will be announced on National Student Day, Oct. 8, 2015.
The most recent Larry Elsasser Memorial Scholarship recipients, Cody Curry and Jeff Seemann, were each awarded $1,000 for the 2015 spring semester. For more information on the award, the link to the application and supervisor evaluation forms, please visit the
Larry Elsasser Memorial Scholarship page
.
For Larry Elsasser Memorial Scholarship Fund donation information, please contact the
.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
An expert pieced together this Roman document like a puzzle
September 1, 2026
National media highlighted a new project by UC Classics Assistant Professor Matthijs Wibier to piece together and translate an ancient Roman text from fragments buried in the desert for more than 1,600 years.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.